Posts tagged “Biotech & Life Science”

Updated January 24, 2007

Premium Lock RTI, Duke, UNC Asheville to Study Chernobyl Radiation Impact

RTI The U.S. Department of Energy is putting $5M into project that will seek to develop radiation diagnostics, treatments.

Updated January 23, 2007

Premium Lock N.C. Biotech Center CEO To Leave March 31

Leslie Alexandre joined Biotech Center in 2002. Leslie Alexandre, who led an aggressive program to expand state's life science industry, plans to pursue other opportunities. 'I give her a lot of credit as a change agent in a positive way,' CED's Monica Doss says.

January 22, 2007

Premium Lock Chelsea Therapeutics Receives 'Orphan' Status for Drug Candidate

FDA approval FDA decision could mean seven years of exclusivity for Droxidopa, a treatment targeting neurogenic disorder.

Updated January 19, 2007

Premium Lock FDA Grants Approval for Optical Imaging Device from Duke Spin-out

Bioptigen Bioptigen can begin marketing its non-invasive scanner for eye disease research. Company also receives two federal research grants

Updated January 19, 2007

Premium Lock GSK to Compare Cancer Vaccine with Merck Product

GSK Drug maker is seeking FDA approval for vaccine to combat cervical cancer.

Updated January 18, 2007

Premium Lock Government Awards GSK, Novartis Huge Contracts for Immune System Booster

GSK to receive $63.3M, Novartis $54.8M to produce adjuvant, a product designed to increase effectiveness of influenza drugs. Novartis will utilize Holly Springs plant for project.

Updated January 12, 2007

Premium Lock Amphora Discovery Names New President

DRUG RESEARCH William Janzen, a longtime Eli Lilly exec, is promoted from CTO post.

Updated January 10, 2007

Premium Lock Emory Launches $110M Global Health Institute

Medical Technology University also partners with Finish group to form international public health alliance with $20M grant from Gates Foundation.

Updated January 10, 2007

Premium Lock Amphora Discovery Sells Oncology Drug Target to Genentech

Amphora Company recently split into two business units, including a contract research organization in Durham.

Updated January 10, 2007

Premium Lock Scynexis Receives $1M Milestone Payment from Merck

Scynexis Companies are working together to develop antifungal products.

Updated January 9, 2007

Premium Lock N.C. Biotech Center Awards $350,000 in Loans to Four Startups

Biotechlogo Morrisville-based Addrenex, RTP-based Teotten receive largest loans - $150,000 each. Two other companies get $25,000.

Updated January 8, 2007

Premium Lock PPD's CEO Plans to Sell Up to 1 Million Shares of Stock

PPD Fred Eshelman owns more than 9 million shares of the Wilmington-based contract research organization.

Updated January 5, 2007

Premium Lock Inspire to Try Again to Win Approval for Dry Eye Drug

Inspire Durham-based pharmaceutical firm to meet with FDA to discuss diquafosol. News sparks rally in stock price.

January 4, 2007

Premium Lock Former Quintiles Executive Joins RTI as Chief Medical Officer

RTI Claude Hughes will also serve as a V.P. in genomics and molecular epidemiology project.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith